Statizoid

Health in High income (World Bank)

155 indicators covering health for High income (World Bank).

IndicatorLatest Year10-yr change Rank
Mean BMI (kg/m²) 26.6 2016 up 1.9% 2nd
Rubella - number of reported cases 592 2025 up 6.5% 9th
Treatment success rate: new TB cases 71 2023 down 2.7% 10th
Yellow fever - number of reported cases 2 2025 down 50.0% 7th
UHC Service Coverage sub-index on infectious diseases 98 2023 up 1.0% 1st
UHC Service Coverage sub-index on service capacity and access 96 2023 unchanged 1st
UHC Service Coverage sub-index on reproductive, maternal, newborn and 84 2023 up 1.2% 3rd
UHC Service Coverage Index 85 2023 up 2.4% 1st
UHC Service Coverage sub-index on noncommunicable diseases 67 2023 up 9.8% 3rd
Stillbirth rate 2.81 2023 down 11.3% 11th
Rotavirus vaccines completed dose (RotaC) immunization coverage among 67.0% 2025 up 81.1% 4th
Current health expenditure (CHE) as percentage of gross domestic 8.1% 2023 up 9.9% 1st
External health expenditure (EXT) as percentage of current health 1.6% 2023 down 11.6% 10th
Domestic general government health expenditure (GGHE-D) as percentage 70.8% 2023 up 3.3% 1st
Out-of-pocket expenditure as percentage of current health expenditure 19.3% 2023 down 8.8% 10th
Domestic general government health expenditure (GGHE-D) as percentage 5.6% 2023 up 12.8% 1st
Domestic general government health expenditure (GGHE-D) as percentage 14.2% 2023 up 12.4% 1st
Domestic private health expenditure (PVT-D) as percentage of current 27.7% 2023 down 6.9% 10th
Current health expenditure (CHE) per capita in US$ 3,673 2023 up 25.0% 1st
Domestic private health expenditure (PVT-D) per capita in US$ 1,026 2023 up 20.5% 1st
Domestic general government health expenditure (GGHE-D) per capita in 2,613 2023 up 26.5% 1st
Mumps - number of reported cases 24,916 2025 down 74.0% 7th
Incidence of tuberculosis (per 100 000 population) 1.3 2023 up 8.3% 9th
Congenital Rubella Syndrome - number of reported cases 7 2025 down 58.8% 9th
External health expenditure (EXT) per capita in US$ 42.09 2023 up 58.7% 2nd
Raised blood pressure (SBP>=140 OR DBP>=90) 20.47 2019 down 13.9% 11th
Raised blood pressure (SBP>=140 OR DBP>=90) 23.25 2019 down 10.9% 11th
Hypertension: diagnosis coverage among adults aged 30-79 with 68.8% 2019 up 6.2% 2nd
Hypertension among adults aged 30-79 years, prevalence 32 2019 down 6.2% 9th
Hypertension effective treatment coverage (controlled hypertension) 36.0% 2019 up 19.2% 2nd
Hypertension: effective treatment coverage (controlled hypertension) 38.0% 2019 up 22.2% 1st
Hypertension treatment coverage among adults aged 30-79 with 62.2% 2019 up 8.2% 1st
Hypertension treatment coverage among adults aged 30-79 with 58.2% 2019 up 6.2% 2nd
Hypertension: diagnosis coverage among adults aged 30-79 with 71.9% 2019 up 7.6% 1st
Hypertension among adults aged 30-79 years, prevalence, crude 37.5 2019 down 1.1% 2nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) 87.0% 2025 up 20.8% 2nd
Treatment success rate: previously treated TB cases 60 2023 up 15.4% 10th
Prevalence of insufficient physical activity among adults aged 18+ 35.7% 2022 up 5.1% 5th
Prevalence of insufficient physical activity among adults aged 18+ 32.7% 2022 up 3.1% 5th
TB patients with known HIV status 79.0% 2024 up 54.9% 8th
Confirmed cases of RR-/MDR-TB 24,580 2024 up 30.2% 7th
Tested TB patients HIV-positive 15.0% 2024 up 117.4% 2nd
New cases tested for RR-/MDR-TB 87.0% 2024 down 1.1% 6th
Age-standardized suicide rates 11.85 2021 down 15.7% 1st
Premature deaths due to noncommunicable diseases (NCD) as a 27.33 2021 down 6.4% 11th
Total NCD Deaths 11.31 million 2021 up 11.3% 5th
Probability (%) of dying between age 30 and exact age 70 from any of 12.9% 2021 down 12.2% 11th
Life expectancy at age 60 23.42 2021 down 1.0% 1st
Age-standardized NCD mortality rate 364.86 2021 down 9.4% 11th
Mortality rate attributed to unintentional poisoning 0.6608 2021 down 32.1% 7th
Life expectancy at birth 79.65 2021 down 0.4% 1st
Adult mortality rate (probability of dying between 15 and 60 years) 107.16 2021 up 0.7% 10th
Previously treated cases tested for RR-/MDR-TB 92.0% 2024 up 155.6% 1st
Healthy life expectancy (HALE) at age 60 17.44 2021 down 1.7% 1st
nMx - age-specific death rate between ages x and x+n 0.0043 2021 down 16.7% 11th
nLx - person-years lived between ages x and x+n 99,620 2021 up 0.1% 1st
lx - number of people left alive at age x 100,000 2021 unchanged 1st
nqx - probability of dying between ages x and x+n 0.0042 2021 down 16.6% 11th
Tx - person-years lived above age x 7.97 million 2021 down 0.4% 1st
Healthy life expectancy (HALE) at birth 68.08 2021 down 1.0% 2nd